Recursion Pharmaceuticals Inc (RXRX)
7.94
+0.24
(+3.12%)
USD |
NASDAQ |
Apr 24, 16:00
7.67
-0.27
(-3.40%)
Pre-Market: 09:23
Recursion Pharmaceuticals 1 Year Total Returns (Daily): 47.04% for April 24, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
Date | Value |
---|---|
April 24, 2024 | 47.04% |
April 23, 2024 | 34.62% |
April 22, 2024 | 32.87% |
April 19, 2024 | 23.32% |
April 18, 2024 | 24.58% |
April 17, 2024 | 19.14% |
April 16, 2024 | 27.44% |
April 15, 2024 | 31.14% |
April 12, 2024 | 36.75% |
April 11, 2024 | 35.98% |
April 10, 2024 | 31.60% |
April 09, 2024 | 36.69% |
April 08, 2024 | 35.34% |
April 05, 2024 | 37.52% |
April 04, 2024 | 32.88% |
April 03, 2024 | 29.61% |
April 02, 2024 | 31.48% |
April 01, 2024 | 40.48% |
March 28, 2024 | 55.30% |
March 27, 2024 | 51.34% |
March 26, 2024 | 54.26% |
March 25, 2024 | 57.40% |
March 22, 2024 | 50.29% |
March 21, 2024 | 43.34% |
March 20, 2024 | 52.48% |
Date | Value |
---|---|
March 19, 2024 | 45.07% |
March 18, 2024 | 54.12% |
March 15, 2024 | 50.00% |
March 14, 2024 | 41.28% |
March 13, 2024 | 43.16% |
March 12, 2024 | 49.08% |
March 11, 2024 | 46.68% |
March 08, 2024 | 38.15% |
March 07, 2024 | 35.15% |
March 06, 2024 | 37.88% |
March 05, 2024 | 40.45% |
March 04, 2024 | 45.05% |
March 01, 2024 | 61.13% |
February 29, 2024 | 65.15% |
February 28, 2024 | 58.77% |
February 27, 2024 | 101.0% |
February 26, 2024 | 93.96% |
February 23, 2024 | 70.32% |
February 22, 2024 | 88.92% |
February 21, 2024 | 60.44% |
February 20, 2024 | 57.57% |
February 16, 2024 | 68.16% |
February 15, 2024 | 47.27% |
February 14, 2024 | 31.09% |
February 13, 2024 | 22.74% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-81.78%
Minimum
Apr 29 2022
101.0%
Maximum
Feb 27 2024
-19.96%
Average
-27.45%
Median
1 Year Total Returns (Daily) Benchmarks
Eli Lilly and Co | 92.58% |
Palatin Technologies Inc | -32.42% |
Oragenics Inc | -64.26% |
Editas Medicine Inc | -32.02% |
BioXcel Therapeutics Inc | -88.17% |